Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 4Sarcoma 2Plasma cell 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Sarcoma 2Melanoma 2Neoplasms 1Multiple Myeloma 1Lymphoma 1Kidney Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 20pembrolizumab 19Nivolumab 10fludarabine 7Radiosurgery 7Specimen Handling 6Ipilimumab 6Injections 5Celecoxib 5poly ICLC 4Radiation 4Paclitaxel 4Melphalan 4Magnetic Resonance Spectroscopy 4Gemcitabine 4Docetaxel 4Cryosurgery 4durvalumab 3cemiplimab 3Filgrastim 3Etoposide 3Cisplatin 3Blood Specimen Collection 3Biopsy 3trastuzumab deruxtecan 2tislelizumab 2talimogene laherparepvec 2spartalizumab 2fludarabine phosphate 2bempegaldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Interferons × Sarcoma × Clear all
NCT00311558 2018-01-26

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

The Cleveland Clinic

Phase 1 Terminated
18 enrolled
DermatologicSarcoma

Melanoma, Neoplasms, Sarcoma

NCT00276536 2015-10-14

IFNa

The Cleveland Clinic

Phase 1 Completed
35 enrolled
BreastDermatologicGenitourinaryLymphoidPlasma cellSarcoma

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡